# K171899: Revitalair 430F

- Pathway: 510(k) (Traditional)
- Applicant: Oxavita Srl
- Decided: Nov 22, 2019 after 879 days
- Product code: CBF (Chamber, Hyperbaric)
- Device class: 2
- Regulation: 21 CFR 868.5470
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 3 generations back to K011312 (2001). 5 ancestors in all.
1 later device descends from it; 1 cites it directly.
0 of 7 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K072757: Dive and Shallow and Grand Dive, Summit TO Sea (2008) Summary page 5.

## Most influential descendants
- K220290: Revitalair 430+ (2023), 0 descendants of its own

## Indications for use
The intended use of the Portable Hyperbaric Chamber Revitalair® 430F is to treat acute mountain sickness under the prescription of a health professional. The medical device is designed for use at physician offices and health institutions.

Source page: https://510kreport.com/device/K171899
Methodology: https://510kreport.com/methodology